This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window

American Economic Journal: Applied Economics: Vol. 2 No. 2 (April 2010)
AEJ: Applied Volume. 2, Issue 2 |
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter Subscription Information
(Institutional Administrator Access)
AEJ: Applied Forthcoming Articles
Full-text Article
Download Data Set (171.92 KB) | Appendix (11.71 KB)
View Comments on This Article (0) | Login to post a comment
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter Subscription Information
(Institutional Administrator Access)
Explore:
AEJ: Applied Forthcoming Articles
Modern Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs
Article Citation
Jayachandran, Seema,
Adriana Lleras-Muney, and
Kimberly V. Smith. 2010. "Modern Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs."
American Economic Journal: Applied Economics,
2(2): 118-46.
DOI: 10.1257/app.2.2.118
DOI: 10.1257/app.2.2.118
Abstract
This paper studies the contribution of sulfa drugs, a groundbreaking
medical innovation in the 1930s, to declines in US mortality. For
several infectious diseases, sulfa drugs represented the first effective
treatment. Using time-series and difference-in-differences methods,
we find that sulfa drugs led to a 24 to 36 percent decline in maternal
mortality, 17 to 32 percent decline in pneumonia mortality, and 52
to 65 percent decline in scarlet fever mortality between 1937 and
1943. Altogether, sulfa drugs reduced mortality by 2 to 3 percent and
increased life expectancy by 0.4 to 0.7 years. We also find that sulfa
drugs benefited whites more than blacks. (JEL I12, L65, N32, N72)
Article Full-Text Access
Full-text Article
Additional Materials
Download Data Set (171.92 KB) | Appendix (11.71 KB)
Authors
Jayachandran, Seema (Stanford U)
Lleras-Muney, Adriana (UCLA)
Smith, Kimberly V. (Mathematica Policy Research, Princeton, NJ)
Lleras-Muney, Adriana (UCLA)
Smith, Kimberly V. (Mathematica Policy Research, Princeton, NJ)
JEL Classifications
I12: Health Production
L65: Chemicals; Rubber; Drugs; Biotechnology
N32: Economic History: Labor and Consumers, Demography, Education, Health, Welfare, Income, Wealth, and Religion: U.S.; Canada: 1913-
N72: Economic History: Transport, Trade, Energy, Technology, and Other Services: U.S.; Canada: 1913-
L65: Chemicals; Rubber; Drugs; Biotechnology
N32: Economic History: Labor and Consumers, Demography, Education, Health, Welfare, Income, Wealth, and Religion: U.S.; Canada: 1913-
N72: Economic History: Transport, Trade, Energy, Technology, and Other Services: U.S.; Canada: 1913-
Comments
View Comments on This Article (0) | Login to post a comment

